- Corporate Officers - D
- Debbane Raymond
Insider Trading History of Debbane Raymond
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Debbane Raymond since 2007.
This trader's CIK number is 1053890.
At the time of last reporting, Debbane Raymond was the Director of Lexicon Pharmaceuticals, Inc.. (stock ticker symbol LXRX).
Also see all insider trading activities at Lexicon Pharmaceuticals, Inc..
Note that in the past
DEBBANE RAYMOND also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Glycomimetics Inc (GLYC) by Debbane Raymond
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | GLYC | 0 | $0 | 2,271,499 | $488,679 | 0 | $0 |
Yearly summary of insider trading at Lexicon Pharmaceuticals, Inc. (LXRX) by Debbane Raymond
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LXRX | 0 | $0 | 0 | $0 | 36,810 | $0 |
| 2024 | LXRX | 0 | $0 | 0 | $0 | 8,032 | $0 |
| 2023 | LXRX | 1,000,000 | $1,103,993 | 0 | $0 | 9,302 | $0 |
| 2022 | LXRX | 1,965,200 | $4,913,000 | 0 | $0 | 4,024 | $0 |
| 2021 | LXRX | 0 | $0 | 0 | $0 | 10,638 | $0 |
| 2020 | LXRX | 0 | $0 | 0 | $0 | 3,466 | $0 |
| 2019 | LXRX | 300,515 | $744,627 | 0 | $0 | 0 | $0 |
| 2014 | LXRX | 465,896 | $417,254 | 0 | $0 | 0 | $0 |
| 2012 | LXRX | 3,000,000 | $6,750,000 | 0 | $0 | 0 | $0 |
| 2010 | LXRX | 94,270,206 | $108,410,736 | 0 | $0 | 0 | $0 |
| 2009 | LXRX | 15,455,145 | $23,182,717 | 0 | $0 | 0 | $0 |
| 2008 | LXRX | 50,824,986 | $192,880,821 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Scholar Rock Holding Corp (SRRK) by Debbane Raymond
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | SRRK | 0 | $0 | 2,009,433 | $82,746,684 | 0 | $0 |
Insider trading activities at 3 companies by Debbane Raymond:
1. Glycomimetics Inc (GLYC)
2. Lexicon Pharmaceuticals, Inc. (LXRX)
3. Scholar Rock Holding Corp (SRRK)
Table 1. Insider trading of Glycomimetics Inc (GLYC) by Debbane Raymond
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-08-07 | GLYC | Sale | 61,488 | .18 | 11,190 |
| 2024-08-08 | GLYC | Sale | 260,873 | .19 | 50,087 |
| 2024-08-05 | GLYC | Sale | 164,523 | .19 | 30,930 |
| 2024-08-06 | GLYC | Sale | 55,732 | .18 | 10,198 |
| 2024-08-02 | GLYC | Sale | 286,200 | .20 | 57,240 |
| 2024-08-01 | GLYC | Sale | 63,564 | .22 | 13,729 |
| 2024-07-26 | GLYC | Sale | 258,335 | .24 | 62,517 |
| 2024-07-29 | GLYC | Sale | 363,949 | .23 | 85,528 |
| 2024-07-30 | GLYC | Sale | 756,835 | .22 | 167,260 |
Table 2. Insider trading of Lexicon Pharmaceuticals, Inc. (LXRX) by Debbane Raymond
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-13 | LXRX | Option Ex | 36,810 | .00 | 0 |
| 2024-04-28 | LXRX | Option Ex | 8,032 | .00 | 0 |
| 2023-10-11 | LXRX | Buy | 342,874 | 1.08 | 370,646 |
| 2023-10-12 | LXRX | Buy | 148,820 | 1.03 | 153,879 |
| 2023-10-10 | LXRX | Buy | 508,306 | 1.14 | 579,468 |
| 2023-05-21 | LXRX | Option Ex | 9,302 | .00 | 0 |
| 2022-08-01 | LXRX | Buy | 982,600 | 2.50 | 2,456,500 |
| 2022-08-01 | LXRX | Buy | 982,600 | 2.50 | 2,456,500 |
| 2022-04-30 | LXRX | Option Ex | 4,024 | .00 | 0 |
| 2021-04-24 | LXRX | Option Ex | 10,638 | .00 | 0 |
| 2020-04-26 | LXRX | Option Ex | 3,466 | .00 | 0 |
| 2019-09-16 | LXRX | Buy | 93,773 | 2.70 | 253,374 |
| 2019-09-13 | LXRX | Buy | 9,269 | 2.46 | 22,848 |
| 2019-09-13 | LXRX | Buy | 197,473 | 2.37 | 468,405 |
| 2014-12-12 | LXRX | Buy | 150,000 | .88 | 132,000 |
| 2014-12-10 | LXRX | Buy | 315,896 | .90 | 285,254 |
| 2012-10-23 | LXRX | Buy | 3,000,000 | 2.25 | 6,750,000 |
| 2010-03-19 | LXRX | Buy | 94,270,206 | 1.15 | 108,410,736 |
| 2009-10-14 | LXRX | Buy | 13,439,257 | 1.50 | 20,158,885 |
| 2009-10-15 | LXRX | Buy | 2,015,888 | 1.50 | 3,023,832 |
| 2008-08-23 | LXRX | Buy | 50,824,986 | 3.79 | 192,880,821 |
Table 3. Insider trading of Scholar Rock Holding Corp (SRRK) by Debbane Raymond
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-12-10 | SRRK | Sale | 1,600,000 | 41.65 | 66,640,000 |
| 2024-11-25 | SRRK | Sale | 409,433 | 39.34 | 16,106,684 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Debbane Raymond
(Director of Lexicon Pharmaceuticals, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.